Recent leadership changes at Copart (CPRT), including CEO Jeff Liaw’s planned departure and the return of former chief executive Jay Adair, combined with index reclassifications, have sharpened investor focus on the stock.

Copart’s share price has been volatile around these announcements, with a 1-day share price return of 4.24% contrasting with a year to date share price decline of 20.55% and a 1 year total shareholder return decline of 39.15%. This suggests momentum has been fading even before the CEO transition and index reclassifications focused attention on future risks and valuation.

If Copart’s recent swings have you thinking about where else capital could go to work, this is a useful moment to broaden your search and check out 20 top founder-led companies

With Copart now trading at a discount to several intrinsic value estimates and analyst targets, the key question is whether recent setbacks have left the stock undervalued, or if the market is already correctly pricing its future growth potential.

Most Popular Narrative: 30.3% Overvalued

According to one of the most followed Copart narratives, a fair value of $23.03 sits below the last close of $30.01, which puts the current debate around the stock squarely on how durable its business model really is.

Copart is a compounding machine wearing the clothes of a salvage yard. It has built the only infrastructure on earth, a two-sided digital marketplace spanning 1M+ registered buyers in 190+ countries, anchored by owned physical storage across 21,000+ irreplaceable acres, capable of converting an insurance industry's inconvenient problem (the totaled car) into global liquidity at scale. The business earns 36% operating margins on a fee-based model that carries zero inventory risk, compounds FCF at 20%+ over a decade, and operates counter-cyclically: recessions raise total-loss frequency as repair costs rise relative to vehicle values.

Want to see what kind of long run free cash flow profile and exit multiple are being used to justify that fair value for Copart? The key tension in this narrative is between high margins, embedded insurer workflows, and the assumptions around how long that compounding can reasonably continue. Curious which specific profitability and growth inputs are doing the heavy lifting in that $23.03 estimate?

Result: Fair Value of $23.03 (OVERVALUED)

However, there are clear pressure points for this Copart thesis, including the share price decline of 39.15% over 1 year and slower recent revenue and net income growth.

Another View on Copart: What the P/E Ratio Signals

The popular Copart narrative argues the stock looks 30.3% overvalued at $30.01 compared with a $23.03 fair value. Yet on a P/E of 17.9x, Copart trades below the US Commercial Services industry at 20.7x, the peer average at 39.4x, and even the 20x fair ratio.

That gap suggests the market is pricing in more risk or lower prospects than these benchmarks imply, which could either limit downside or reflect concerns that do not show up cleanly in earnings today. The real question is whether you see that discount as a cushion or a warning signal.

For a closer look at how these earnings multiples stack up against what the numbers imply, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If the mixed signals around Copart have you unsure which way sentiment should lean, this is the time to look closely at the facts and shape your own view. Start with the 4 key rewards.

Looking for more investment ideas beyond Copart?

If Copart has sharpened your thinking, do not stop there. Use this momentum to line up your next set of high conviction ideas with a focused stock search.

• Target resilient potential by reviewing companies screened as 74 resilient stocks with low risk scores that may offer a steadier ride when markets get choppy.
• Hunt for value opportunities by scanning screener containing 18 high quality undiscovered gems that many investors may not be watching yet.
• Prioritize balance sheet strength by filtering for companies in the solid balance sheet and fundamentals stocks screener (47 results) that pair financial resilience with fundamental support.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.